Could a diabetes pill save kidneys? new trial aims to find out
Disease control
Recruiting now
This study tests whether a daily pill called sotagliflozin can slow kidney function loss in people with type 1 diabetes who already have moderate to severe kidney disease. About 150 participants will take either the drug or a placebo for 3 years, while following a special plan to…
Phase: PHASE3 • Sponsor: Alessandro Doria • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC